Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 May 2022 for Immuneering Corp, €4,258. Read the official filing
Filing timeline
BuySaleBiren Amin
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+35.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Biren Amin: trading record in brief
This profile gathers the share dealings of Biren Amin in Immuneering Corp. In total, 2 filings cover trades dated from 3 August 2021 to 12 May 2022.
Every open-market trade on record is a purchase: 1 purchase worth €4,258, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2022 to date brings 1 purchase and no sales.
Most recently, on 12 May 2022, the filings show an open-market purchase worth €4,258 in Immuneering Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Biren Amin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,000 shares@ US$4.42100.0% of flowClass A Common StockSEC:0001415889-22-004919:0
Canonical exit: 10 Aug 2022 (T+90)
2,723 sharesClass A Common StockSEC:0001104659-21-099723:0
2 of 2 declarations
